Patent · US Active

Compositions against cancer antigen LIV-1 and uses thereof

US8313745B2 · kind B2 · utility

4Cited by
11References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 8, 2010
Grant dateNov 20, 2012
Priority date—
Expiry dateJun 8, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.